| Fund ID | 805-2545304640 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 2% |
| Owned by non-U.S. persons | 44% |
| Fund | Type | Gross assets |
|---|---|---|
| Sofinnova Bioequities Enhanced Master Fund, LP | Hedge | $834.3M |
| Sofinnova Venture Partners IX, L.P. | Venture Capital | $320.2M |
| Sofinnova Venture Partners X, L.P. | Venture Capital | $293.9M |
Sofinnova Venture Partners XI, L.P. reports $218.6 million in gross assets, among the top 29% of private funds by size.
The stated minimum investment is $500,000.
Sofinnova Venture Partners XI, L.P. is managed by Sofinnova Investments, Inc.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.